Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency
- PMID: 15610810
- DOI: 10.1016/S0140-6736(04)17596-X
Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency
Abstract
3-phosphoglycerate-dehydrogenase (3-PGDH) deficiency is an L-serine biosynthesis disorder, characterised by congenital microcephaly, severe psychomotor retardation, and intractable seizures. We report prenatal diagnosis of an affected fetus by DNA mutation analysis. Ultrasound assessment showed a reduction in fetal head circumference from the 75th percentile at 20 weeks' gestation to the 29th percentile at 26 weeks. L-serine was then given to the mother, which resulted in an enlarged fetal head circumference to the 76th percentile at 31 weeks. At birth, the girl's head circumference was normal, and at 48 months' follow-up, her psychomotor development has been unremarkable. 3-PGDH deficiency is an inborn metabolic error that can be successfully treated antenatally.
Comment in
-
Treating rare inborn errors of metabolism.Lancet. 2004 Dec 18-31;364(9452):2158-60. doi: 10.1016/S0140-6736(04)17606-X. Lancet. 2004. PMID: 15610786 No abstract available.
Similar articles
-
Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency.Ann Neurol. 1998 Aug;44(2):261-5. doi: 10.1002/ana.410440219. Ann Neurol. 1998. PMID: 9708551
-
Two new cases of serine deficiency disorders treated with l-serine.Eur J Paediatr Neurol. 2016 Jan;20(1):53-60. doi: 10.1016/j.ejpn.2015.10.007. Epub 2015 Nov 5. Eur J Paediatr Neurol. 2016. PMID: 26610677
-
3-Phosphoglycerate dehydrogenase deficiency: description of two new cases in Tunisia and review of the literature.Neuropediatrics. 2013 Oct;44(5):281-5. doi: 10.1055/s-0033-1338133. Epub 2013 Apr 6. Neuropediatrics. 2013. PMID: 23564319 Review.
-
Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings.Neuropediatrics. 2001 Aug;32(4):191-5. doi: 10.1055/s-2001-17373. Neuropediatrics. 2001. PMID: 11571699
-
Treatment with amino acids in serine deficiency disorders.J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):347-51. doi: 10.1007/s10545-006-0269-0. J Inherit Metab Dis. 2006. PMID: 16763900 Review.
Cited by
-
Effects of L-serine ingestion on human sleep.Springerplus. 2014 Aug 22;3:456. doi: 10.1186/2193-1801-3-456. eCollection 2014. Springerplus. 2014. PMID: 25197619 Free PMC article.
-
D-serine influences synaptogenesis in a p19 cell model.JIMD Rep. 2012;6:47-53. doi: 10.1007/8904_2011_116. Epub 2012 Feb 1. JIMD Rep. 2012. PMID: 23430939 Free PMC article.
-
The complexity of the serine glycine one-carbon pathway in cancer.J Cell Biol. 2020 Jan 6;219(1):e201907022. doi: 10.1083/jcb.201907022. J Cell Biol. 2020. PMID: 31690618 Free PMC article. Review.
-
D-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders.Transl Psychiatry. 2020 Jun 9;10(1):184. doi: 10.1038/s41398-020-00870-x. Transl Psychiatry. 2020. PMID: 32518273 Free PMC article. Review.
-
A yeast-based complementation assay elucidates the functional impact of 200 missense variants in human PSAT1.J Inherit Metab Dis. 2020 Jul;43(4):758-769. doi: 10.1002/jimd.12227. Epub 2020 Feb 27. J Inherit Metab Dis. 2020. PMID: 32077105 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous